Sun Min Lim

17PUBLICATIONS

149CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Chemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|May 31, 2026

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|Apr 20, 2026

A Phase 2 Study of Stereotactic Ablative Radiotherapy Plus Atezolizumab Plus Tiragolumab in Treatment-naïve Patients with Advanced Non-small Cell Lung Cancer.

|Feb 06, 2026

JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.

Eun Ji Lee, Ji Ae Ko, Min-Je Kim

|Dec 05, 2024

Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab.

Dong Kwon Kim, Chun-Bong Synn, Wongeun Lee

|Oct 24, 2024

BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer.

Sun Min Lim, Stefanie S Schalm, Eun Ji Lee

|Jun 25, 2024

Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.

Sun M Lim, Seong-San Kang, Dong K Kim

Pageof 3

Frequent Collaborators

10 joint publications

Byoung Chul Cho

Min Hee Hong

Jii Bum Lee

Eun Ji Lee

Jae Hwan Kim

Dong Kwon Kim

Mi Ran Yun

Seung Yeon Oh

You-Won Lee

Kyoung-Ho Pyo

Frequent Collaborators

10 joint publications

Byoung Chul Cho

8 joint publications

Min Hee Hong

6 joint publications

Jii Bum Lee

5 joint publications

Eun Ji Lee